SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Spyrou S.)
 

Search: WFRF:(Spyrou S.) > Increased expressio...

  • Cunnea, P.Department of Biosciences and Nutrition at NOVUM, Karolinska Institutet, Stockholm, Sweden (author)

Increased expression of specific thioredoxin family proteins; a pilot immunohistochemical study on human hepatocellular carcinoma

  • Article/chapterEnglish2007

Publisher, publication year, extent ...

  • Biolife,2007
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:liu-98711
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-98711URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:12133689URI
  • https://doi.org/10.1177/039463200702000103DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Hepatocellular Carcinoma (HCC) is one of the most frequent cancers worldwide, however, prognosis remains poor following its discovery. We investigate the Thioredoxin superfamily of proteins as diagnostic markers for HCC. Furthermore, we delineate possible roles of the endoplasmic reticulum member of the superfamily, ERdj5, in carcinogenesis. Using antibodies against Thioredoxin 1, Thioredoxin Reductase 1 and ERdj5, we performed immunohistochemistry on paraffin embedded liver biopsy sections from HCC patients. All three redox proteins exhibited elevated expression levels in tumor tissue compared to internal control, with ERdj5 showing a remarkable 3-fold increase. In vitro cell viability experiments using Hepatocellular Carcinoma HuH7 cells treated with ERdj5 small interfering RNA showed that ERdj5 knockdown cells exhibited less resistance to Doxorubicin (chemotherapy drug), but more resistance to Tunicamycin (Endoplasmic Stress inducer), compared to control cells. In conclusion, we introduce members of the Thioredoxin superfamily as possible immunohistochemical markers in the diagnostics of hepatocellular carcinoma and indicate a potential defensive role for ERdj5 in chemotherapeutic drug resistance.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Fernandes, APKarolinska Institutet (author)
  • Capitanio, A.Department of Laboratory Medicine, Pathology Division, Karolinska University Hospital, Huddinge, Stockholm, Sweden (author)
  • Eken, S.Department of Laboratory Medicine, Pathology Division, Karolinska University Hospital, Huddinge, Stockholm, Sweden (author)
  • Spyrou, GiannisDepartment of Biosciences and Nutrition at NOVUM, Karolinska Institutet, Stockholm / Foundation for Biomedical Research, Academy of Athens, Athens, Greece(Swepub:liu)ioasp42 (author)
  • Björnstedt, M.Karolinska Institutet (author)
  • Karolinska InstitutetDepartment of Biosciences and Nutrition at NOVUM, Karolinska Institutet, Stockholm, Sweden (creator_code:org_t)

Related titles

  • In:International journal of immunopathology and pharmacology: Biolife20:1, s. 17-240394-63202058-7384

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view